SOLVE Research & Consultancy

Executive Summary

SOLVE Research & Consultancy is a Swedish contract analytical laboratory founded in 2016, specializing in advanced biophysical characterization of biomolecules and nanoparticles. The company provides critical services such as aggregation analysis, stability testing, and molecular weight distribution using techniques like FFF-MALS, SEC-MALS, AUC, and DLS. With a focus on serving global biopharma and advanced materials clients, SOLVE has established itself as a reliable partner for quality control and R&D support. The growing demand for high-resolution biophysical characterization, particularly in the development of complex biologics and nanomedicines, positions the company for steady growth. While the company operates in a niche but essential segment of the drug development value chain, its private status and lack of disclosed financials limit visibility. Nevertheless, its technical expertise and established client base provide a solid foundation for future expansion.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Laboratory Capacity and Service Menu70% success
• Q2 2027Strategic Partnership with a Major Biopharma Company50% success
• Q1 2027Achievement of ISO 17025 Accreditation80% success